Market Snapshot

BSE Sensex: 75237.99 -0.21%
BSE 500: 35236.5 -0.36%
BSE 200: 10986.48 -0.35%
BSE 100: 25051.12 -0.28%
BSE BANKEX: 60489.34 -0.77%
BSE IT: 26964.26 1.06%
Nifty 50: 23643.5 -0.19%
Nifty 500: 22531.15 -0.36%
Nifty 200: 13596.35 -0.36%
Nifty 100: 24572.15 -0.33%
Nifty Midcap 100: 60567.15 -0.45%
Nifty Small 100: 17882.6 -0.61%
Nifty IT: 27716.9 1.30%
Nifty PSU Bank: 8027.2 -1.80%

News:

Azad Engineering Q4 PAT climbs...
Atul Auto Q4 PAT surges 107% Y...
SAIL reports 43% surge in Q4 P...
Greenpanel Industries clocks P...
Shriram Asset Management Compa...

Venus Remedies Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

15 May 2026 | 03:59 PM

913.05

-26.65 (-2.84%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

179.95%

Return (1Y)

Beaten BSE Sensex by 188.78%
More Volatile

3.26%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.44%
Not so consistent

6/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

1,119

315

News & Announcements

Venus Remedies to discuss results
1 day ago

Venus Remedies to discuss results

16 - May - 2026 12:00 | 1 day ago

Venus Remedies will hold a meeting of the Board of Directors of the Company on 26 May 2026.
Venus Remedies consolidated net profit rises 30.51% in the December 2025 quarter
107 days ago

Venus Remedies consolidated net profit rises 30.51% in the December 2025 quarter

30 - Jan - 2026 12:00 | 107 days ago

Net profit of Venus Remedies rose 30.51% to Rs 25.58 crore in the quarter ended December 2025 as against Rs 19.60 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 180.26 crore in the quarter ended December 2025 as against Rs 176.52 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 180.26 176.52 2

OPM % 20.81 10.21 -

PBDT 40.03 20.38 96

PBT 33.47 14.97 124

NP 25.58 19.60 31

Powered by Capital Market - Live News
Venus Remedies to hold board meeting
118 days ago

Venus Remedies to hold board meeting

19 - Jan - 2026 12:00 | 118 days ago

Venus Remedies will hold a meeting of the Board of Directors of the Company on 29 January 2026.
Powered by Capital Market - Live News
Venus Remedies receives marketing authorisation for Ceftazidime + Avibactam in Indonesia
129 days ago

Venus Remedies receives marketing authorisation for Ceftazidime + Avibactam in Indonesia

08 - Jan - 2026 12:00 | 129 days ago

Venus Remedies has received marketing authorisation in Indonesia for its antibiotic combination Ceftazidime + Avibactam, granted by the relevant Indonesian drug regulatory authority. This approval marks the first marketing authorisation for Ceftazidime + Avibactam for the Company in Indonesia.

The product is indicated for the treatment of serious infections caused by multi-drug resistant gram-negative pathogens, including complicated intra-abdominal infections and complicated urinary tract infections
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Venus Remedies Ltd has increased by 23.85% since past 3 Months
FII shareholding in Venus Remedies Ltd has increased by 108.75% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	180.26	176.52	2
OPM %	20.81	10.21	-
PBDT	40.03	20.38	96
PBT	33.47	14.97	124
NP	25.58	19.60	31

General Notifications

My Notifications

Research Notifications

Venus Remedies Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

913.05 -26.65 (-2.84%)

News & Announcements

Price vs Volume

Stock Trivia

Venus Remedies Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

913.05

-26.65 (-2.84%)